The study hypothesis that SCN9A gain-of-function variants should cause increased olfactory acuity as SCN9A loss-of-function variants induce anosmia, was verified by inverse concluding that the presence of wild-type genetics was associated with the opposite effects, i.e., reduced pain perception and olfactory acuity. The gene discussed is SCN9A; the disease is Kallmann syndrome.